Address
304 North Cardinal St.
Dorchester Center, MA 02124
Work Hours
Monday to Friday: 7AM - 7PM
Weekend: 10AM - 5PM
MVP DEVELOPMENT
About RenalTrack
Better tracking.
More informed care.
RenalTrack is a digital health-monitoring platform being developed to help authorised screening personnel record selected urine-test results, maintain screening records and observe changes over time.
Our focus is simple: make screening information easier to organise, follow up and use as part of an appropriate healthcare pathway.
Structured records
Result monitoring
Responsible screening
R
RenalTrack
PRODUCT PREVIEW
Screening record overview
Illustrative interface concept
Participant record
A structured record linked to an
authorised screening workflow.
Result history
A framework for reviewing documented
results across screening visits.
Follow-up documentation
Record appropriate next steps in
accordance with approved procedures.
Concept illustration only. This is not a live patient record, an actual screening result, a clinical risk score or a validated interpretation interface.
Our Perspective
RenalTrack is more than a website. It is a health-monitoring product designed to connect structured screening records, result history and responsible follow-up.
Understanding the Platform
What is RenalTrack?
RenalTrack is a digital platform designed to support the organised documentation and longitudinal monitoring of selected urine-test screening results.
In its intended screening workflow, a trained or otherwise authorised healthcare worker, such as a pharmacist or community health worker, performs the screening in accordance with the approved protocol and the manufacturer's instructions for the selected urine reagent strip.
The relevant observations and results can then be documented within the platform's supported workflow. Where repeat records are available, they can help the authorised user review how documented results have changed over time.
RenalTrack is being developed to make this process more structured. It does not turn a urine-strip result into a confirmed diagnosis or replace clinical judgement.
The core idea
A screening result is one piece of information. Its meaning depends on the test method, the quality of the procedure, the person's circumstances and the appropriate clinical assessment.
RenalTrack aims to help keep screening information organised so that changes can be reviewed and appropriate follow-up can be documented.
Monitoring, not diagnosis
RenalTrack supports documentation and monitoring. Diagnosis and treatment decisions belong to appropriately qualified healthcare professionals.
The Need
Why RenalTrack is being developed
Screening information becomes more useful when it is documented carefully, interpreted within its limitations and connected to an appropriate follow-up pathway.
Organised documentation
Provide a structured way to maintain screening records, subject to the platform's approved functionality and operating procedures.
Review over time
Support the review of repeat documented results, helping authorised personnel recognise changes that may warrant professional assessment.
Responsible follow-up
Help keep follow-up actions and referrals connected to the screening record where supported by the approved workflow.
Intended Users
Who is RenalTrack for?
RenalTrack is being developed primarily for authorised personnel who conduct or support screening activities within an appropriate professional setting.
Pharmacists
Pharmacists involved in approved screening activities may use a structured digital workflow to document relevant observations and support appropriate referral decisions within their professional scope.
Community health workers
Community health workers authorised and trained for the relevant screening activities may use structured records to support documentation and follow-up under the applicable protocol.
Screening programme teams
Approved programme coordinators may benefit from better-organised screening records and operational oversight where the implemented system provides those functions and appropriate access controls.
What about the people being screened?
The people whose screening results are recorded are the intended beneficiaries of the screening process. RenalTrack is not presented as a substitute for a clinical consultation or as a self-diagnosis tool. Access to screening records must follow the approved consent, privacy and authorisation procedures.
The Screening Workflow
How RenalTrack is intended to work
The platform is being designed around a documented screening process, with each stage following the approved pilot protocol.
01
Registration and consent
Establish the appropriate participant record, explain the screening process, document consent where required and collect only information justified by the approved protocol.
02
Screening preparation
The authorised screening worker checks the selected strip's instructions, suitability, storage, expiry and required procedure before testing.
03
Urine-strip testing
The screening worker performs the test according to the manufacturer's instructions and the approved operational protocol, including any specified timing requirements.
04
Record the observations
Relevant observations and results are documented using only the fields, units, categories and interpretation rules approved for the selected strip.
05
Review and follow-up
The authorised worker reviews the information within the limits of the screening protocol and arranges appropriate clinical assessment or referral when indicated.
06
Monitor repeat records
Where follow-up screenings are conducted and recorded, the available history can support review of changes over time. Trends alone do not establish a diagnosis.
A protocol-led process
This describes the intended workflow, not a claim that every stage is already implemented or clinically validated. The operational pilot protocol and the actual deployed system determine which functions are available.
Scientific and Technical Foundation
Why test-strip validation matters
A digital platform must not invent the meaning of a urine-strip colour or substitute an assumed range for a manufacturer's validated reference.
Different reagent strips can use different parameters, scales, units, reaction times and colour-reference charts. Even where two products measure a similarly named parameter, their interpretation rules must not automatically be treated as interchangeable.
RenalTrack's screening implementation therefore depends on identifying the specific strip selected for the pilot and verifying the applicable manufacturer's instructions and reference chart.
- Confirm the exact strip brand and model.
- Obtain and review the official manufacturer documentation.
- Map supported parameters, units, categories and reference values.
- Verify the mapping against the approved protocol before operational use.
- Document version changes and repeat the necessary verification when the strip or mapping changes.
Important: no guessed interpretations
RenalTrack must not publish assumed urine-strip colour mappings or Low / Moderate / High classifications as validated screening interpretations.
Such mappings must only be implemented after the selected strip and its official reference documentation have been established and the mapping has been appropriately verified.
A urine reagent strip is a screening instrument. Results may be affected by factors such as specimen handling, timing, interference and the specific product's limitations.
Product Capabilities
What RenalTrack is designed to support
The product's value lies in the relationship between screening records, monitoring and responsible operational follow-up.
Participant records
A structured record for the screening participant, governed by the approved registration and consent process.
Screening history
Organisation of recorded screening encounters so that authorised personnel can review the available history.
Result monitoring
A basis for reviewing repeat recorded results over time, once the required test-strip mapping and workflow are validated.
Follow-up documentation
Recording appropriate next steps according to the deployed workflow and the approved screening protocol.
Operational records
Support for programme documentation and screening administration where the relevant reporting functions have been implemented.
Privacy-conscious handling
An approach that should minimise unnecessary data collection and restrict access to authorised users under applicable privacy requirements.
These are product objectives and intended capabilities. They should not be read as a representation that every feature is live, clinically validated or available in the current MVP.
Responsible Use
What RenalTrack is — and what it is not
RenalTrack is intended to be
- A digital health-monitoring and record-keeping platform.
- A tool for organising selected urine-screening information.
- A way to review available screening records over time.
- A potential support for appropriate follow-up documentation.
- A product governed by validated mappings, approved workflows and clear operational limits.
RenalTrack is not
- A diagnostic device or autonomous diagnostic system.
- A replacement for laboratory testing or clinical assessment.
- A substitute for a qualified healthcare professional.
- A guarantee that a person does or does not have kidney disease.
- A justification for starting, stopping or changing treatment without appropriate clinical advice.
Screening is not diagnosis
A urine-strip finding by itself cannot establish kidney disease. A normal screening result also cannot rule out every kidney or urinary condition. Appropriate assessment may require clinical history, examination, laboratory investigations and other tests.
Our Principles
What guides RenalTrack
Trustworthy health technology requires more than an attractive interface. It requires appropriate boundaries, clear processes and responsible handling of sensitive information.
01
Accuracy before automation
Test-strip mappings and interpretation rules must be based on the correct product documentation and verified before use.
02
People before data
Screening records should serve an appropriate care pathway, with informed consent and suitable privacy protections.
03
Clarity before claims
Product capabilities, validation status and clinical limitations must be communicated honestly.
04
Monitoring with context
Changes in recorded results should be considered in context and must not be treated as a diagnosis.
05
Privacy by design
Data collection, access, retention and disclosure should follow applicable law and the approved privacy and security procedures.
06
Continuous improvement
Pilot findings, technical testing and appropriate professional feedback should guide product improvement before wider deployment.
Privacy and Data Responsibility
Health information deserves care
Screening records can contain sensitive personal information. Their collection and use must be justified, controlled and transparent.
RenalTrack's privacy approach should follow the published Privacy Policy, the approved pilot protocol and applicable data-protection requirements. Access should be limited to people who are authorised to perform their assigned responsibilities.
Appropriate safeguards should cover account access, secure transmission, record handling, retention, incident response and the management of participant requests.
Read the Privacy Policy →Our privacy commitments
- Collect only information needed for defined and legitimate purposes.
- Apply appropriate consent and participant-information procedures.
- Limit access according to authorised responsibilities.
- Use suitable technical and organisational security measures.
- Handle retention, disclosure and deletion under approved procedures and applicable law.
Actual protections depend on the implemented system, its configuration and the operational policies in force.
Product Development
Building RenalTrack responsibly
RenalTrack is in MVP development. The objective is to establish a reliable, appropriately bounded screening-monitoring workflow before expanding the product.
Product and workflow readiness
Define the intended users, registration process, consent requirements, screening record structure, follow-up workflow and access responsibilities.
Test-strip verification
Confirm the exact pilot strip and verify its official instructions and reference chart before implementing interpretation logic.
Technical quality assurance
Test the relevant application functions, permissions, record handling, error conditions and recovery procedures.
Pilot readiness
Establish the necessary operational procedures, staff guidance, privacy controls, limitations and escalation pathways before authorised pilot use.
Development status is not validation
Technical completion alone does not establish clinical validity, diagnostic performance, regulatory clearance or readiness for unrestricted deployment. Those matters require the relevant evidence and approvals.
Quick Answers
Frequently asked questions
1. Is RenalTrack a medical diagnostic tool?
No. RenalTrack is designed for monitoring and documenting selected urine-screening results. It does not independently diagnose kidney disease or replace professional assessment.
2. Who is expected to use RenalTrack?
Its primary intended users are authorised screening personnel, including pharmacists and community health workers, operating within the approved protocol and their professional scope.
3. Does RenalTrack perform the urine test?
No. The physical screening is performed using the selected urine reagent strip according to its instructions. RenalTrack is the digital platform intended to document and monitor the resulting screening information.
4. How will urine-strip results be interpreted?
Interpretation must follow the exact selected strip's official instructions and verified reference chart. Assumed colour ranges or unverified classifications must not be substituted for that mapping.
5. Can RenalTrack identify kidney disease?
No. Urine-strip findings alone cannot confirm or exclude every kidney condition. Concerning findings, persistent changes or symptoms should be assessed by a qualified healthcare professional.
6. Why monitor results over time?
Repeat records may help authorised personnel review changes and determine whether further assessment is appropriate. A pattern in screening results is not itself a diagnosis.
7. Is RenalTrack fully launched?
RenalTrack is currently identified as an MVP-development product. The functions and permitted uses of any pilot deployment depend on its implementation, validation and operational readiness.
8. What should I do if a result concerns me?
Speak with a qualified healthcare professional for appropriate assessment. Do not delay urgent medical attention because a screening result appears normal. Severe symptoms or an emergency require prompt medical care.
The RenalTrack Approach
Better organised information. More responsible follow-up.
RenalTrack is being developed to support a more structured approach to screening documentation and screening results and referral, grounded in validated procedures, appropriate professional judgement and responsible data handling.
